PARIS, FRANCE and CHARLOTTESVILLE, VA / ACCESSWIRE / April 18, 2017 / Cellnovo Group ("Cellnovo" EN Paris: CLNV), a medical technology company marketing the first mobile, connected, all-in-one diabetes management system, and digital health company TypeZero Technologies, today announce the completion of a worldwide commercial license agreement for the integration and the commercialization of TypeZero's Artificial Pancreas (AP) technology into Cellnovo's mobile diabetes management system. The...
VIDEO FINANCIAL REPORTING Why invest in is the first financial video platform where you can easily search through thousands of videos describing global ......
VIDEO FINANCIAL REPORTING Why invest in is the first financial video platform where you can easily search through thousands of videos describing global ......